(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1354498 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA3 mRNA CTD PMID:22079256 1,2-dichloroethane decreases expression ISO RGD:1558377 6480464 ethylene dichloride results in decreased expression of RPS6KA3 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1558377 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPS6KA3 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1558377 6480464 1, 2-Dimethylhydrazine results in decreased expression of RPS6KA3 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of RPS6KA3 mRNA CTD PMID:21983209 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:1354498 6480464 Dinitrochlorobenzene binds to RPS6KA3 protein CTD PMID:32991956 17alpha-ethynylestradiol multiple interactions ISO RGD:1558377 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPS6KA3 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1354498 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of RPS6KA3 mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of RPS6KA3 mRNA CTD PMID:19619570 , PMID:20660070 17beta-estradiol increases expression ISO RGD:1354498 6480464 Estradiol results in increased expression of RPS6KA3 mRNA CTD PMID:15757668 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1354498 6480464 Dihydrotestosterone results in increased expression of RPS6KA3 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1558377 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1558377 6480464 2 more ... CTD PMID:30294300 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1558377 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1354498 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of RPS6KA3 mRNA, [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of RPS6KA3 mRNA CTD PMID:19619570 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RPS6KA3 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPS6KA3 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1354498 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPS6KA3 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1558377 6480464 Tetrachlorodibenzodioxin affects the expression of RPS6KA3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1558377 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPS6KA3 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1558377 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPS6KA3 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1354498 6480464 Tetrachlorodibenzodioxin results in increased expression of RPS6KA3 mRNA CTD PMID:19619570 2-hydroxypropanoic acid decreases expression ISO RGD:1354498 6480464 Lactic Acid results in decreased expression of RPS6KA3 mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1558377 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of RPS6KA3 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide decreases expression ISO RGD:1558377 6480464 Fenretinide results in decreased expression of RPS6KA3 mRNA CTD PMID:28973697 4-vinylcyclohexene dioxide affects expression ISO RGD:1558377 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of RPS6KA3 mRNA CTD PMID:20829426 acetamide increases expression EXP 6480464 acetamide results in increased expression of RPS6KA3 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:1558377 6480464 Aflatoxin B1 results in increased expression of RPS6KA3 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1354498 6480464 Aflatoxin B1 results in decreased methylation of RPS6KA3 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:1354498 6480464 Aflatoxin B1 results in decreased expression of RPS6KA3 mRNA CTD PMID:21641981 Aflatoxin B2 alpha increases methylation ISO RGD:1354498 6480464 aflatoxin B2 results in increased methylation of RPS6KA3 intron CTD PMID:30157460 all-trans-retinoic acid multiple interactions ISO RGD:1354498 6480464 RPS6KA3 protein promotes the reaction [Tretinoin results in increased phosphorylation of CREB1 protein] CTD PMID:16280361 all-trans-retinoic acid decreases expression ISO RGD:1354498 6480464 Tretinoin results in decreased expression of RPS6KA3 mRNA CTD PMID:15498508 all-trans-retinoic acid increases expression ISO RGD:1354498 6480464 Tretinoin results in increased expression of RPS6KA3 mRNA CTD PMID:21934132 aristolochic acid A decreases expression ISO RGD:1354498 6480464 aristolochic acid I results in decreased expression of RPS6KA3 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1354498 6480464 arsenite inhibits the reaction [G3BP1 protein binds to RPS6KA3 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:1558377 6480464 Arsenic Trioxide results in decreased expression of RPS6KA3 mRNA CTD PMID:24831965 atrazine increases expression ISO RGD:1354498 6480464 Atrazine results in increased expression of RPS6KA3 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1354498 6480464 Benzo(a)pyrene results in decreased expression of RPS6KA3 mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects methylation ISO RGD:1354498 6480464 Benzo(a)pyrene affects the methylation of RPS6KA3 exon more ... CTD PMID:27901495 , PMID:30157460 bisphenol A increases expression ISO RGD:1558377 6480464 bisphenol A results in increased expression of RPS6KA3 mRNA CTD PMID:26063408 bisphenol A affects expression ISO RGD:1354498 6480464 bisphenol A affects the expression of RPS6KA3 mRNA CTD PMID:30903817 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of RPS6KA3 mRNA CTD PMID:31129395 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RPS6KA3 mRNA CTD PMID:31129395 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of RPS6KA3 gene CTD PMID:28505145 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RPS6KA3 mRNA CTD PMID:25181051 butanal decreases expression ISO RGD:1354498 6480464 butyraldehyde results in decreased expression of RPS6KA3 mRNA CTD PMID:26079696 cadmium dichloride increases phosphorylation ISO RGD:1354498 6480464 Cadmium Chloride results in increased phosphorylation of RPS6KA3 protein CTD PMID:24057571 caffeine decreases expression ISO RGD:1354498 6480464 Caffeine results in decreased expression of RPS6KA3 mRNA CTD PMID:11793227 caffeine affects phosphorylation ISO RGD:1354498 6480464 Caffeine affects the phosphorylation of RPS6KA3 protein CTD PMID:35688186 calcitriol increases expression ISO RGD:1354498 6480464 Calcitriol results in increased expression of RPS6KA3 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1354498 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of RPS6KA3 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO RGD:1354498 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of RPS6KA3 mRNA CTD PMID:30096889 capsaicin increases expression ISO RGD:1354498 6480464 Capsaicin results in increased expression of RPS6KA3 protein CTD PMID:18991268 carbamazepine affects expression ISO RGD:1354498 6480464 Carbamazepine affects the expression of RPS6KA3 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1558377 6480464 Nanotubes more ... CTD PMID:25554681 choline multiple interactions ISO RGD:1558377 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RPS6KA3 mRNA CTD PMID:20938992 cisplatin decreases expression ISO RGD:1354498 6480464 Cisplatin results in decreased expression of RPS6KA3 mRNA CTD PMID:27392435 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of RPS6KA3 mRNA CTD PMID:24386269 cocaine multiple interactions ISO RGD:1558377 6480464 RPS6KA3 affects the reaction [Cocaine results in increased phosphorylation of FOS protein] more ... CTD PMID:16339038 copper atom multiple interactions ISO RGD:1354498 6480464 [Chelating Agents binds to Copper] which results in increased expression of RPS6KA3 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1354498 6480464 [Chelating Agents binds to Copper] which results in increased expression of RPS6KA3 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:1354498 6480464 Copper Sulfate results in increased expression of RPS6KA3 mRNA CTD PMID:20599845 coumarin affects phosphorylation ISO RGD:1354498 6480464 coumarin affects the phosphorylation of RPS6KA3 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:1558377 6480464 Asbestos, Crocidolite results in decreased expression of RPS6KA3 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:1354498 6480464 Cyclosporine results in decreased expression of RPS6KA3 mRNA CTD PMID:20106945 , PMID:25562108 daidzein increases expression ISO RGD:1354498 6480464 daidzein results in increased expression of RPS6KA3 mRNA CTD PMID:15757668 diarsenic trioxide decreases expression ISO RGD:1558377 6480464 Arsenic Trioxide results in decreased expression of RPS6KA3 mRNA CTD PMID:24831965 doxorubicin decreases expression ISO RGD:1354498 6480464 Doxorubicin results in decreased expression of RPS6KA3 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO RGD:1354498 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPS6KA3 protein CTD PMID:23301498 ethanol decreases expression ISO RGD:1558377 6480464 Ethanol results in decreased expression of RPS6KA3 mRNA CTD PMID:29018328 ethanol affects splicing ISO RGD:1558377 6480464 Ethanol affects the splicing of RPS6KA3 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1558377 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 genistein increases expression ISO RGD:1354498 6480464 Genistein results in increased expression of RPS6KA3 mRNA CTD PMID:15757668 glycitein increases expression ISO RGD:1354498 6480464 glycitein results in increased expression of RPS6KA3 mRNA CTD PMID:15757668 hydrogen peroxide multiple interactions ISO RGD:1558377 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 hydroquinone O-beta-D-glucopyranoside increases expression ISO RGD:1354498 6480464 Arbutin results in increased expression of RPS6KA3 mRNA CTD PMID:17103032 inulin multiple interactions ISO RGD:1558377 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RPS6KA3 mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:1354498 6480464 Ivermectin results in decreased expression of RPS6KA3 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1558377 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RPS6KA3 mRNA CTD PMID:20938992 lycopene decreases expression ISO RGD:1354498 6480464 lycopene results in decreased expression of RPS6KA3 protein CTD PMID:17337101 menadione affects expression ISO RGD:1354498 6480464 Vitamin K 3 affects the expression of RPS6KA3 mRNA CTD PMID:20044591 methotrexate affects expression ISO RGD:1558377 6480464 Methotrexate affects the expression of RPS6KA3 mRNA CTD PMID:18502557 methyl methanesulfonate decreases expression ISO RGD:1354498 6480464 Methyl Methanesulfonate results in decreased expression of RPS6KA3 mRNA CTD PMID:23649840 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases activity ISO RGD:1354498 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of RPS6KA3 protein CTD PMID:10998351 nickel atom increases expression ISO RGD:1354498 6480464 Nickel results in increased expression of RPS6KA3 mRNA CTD PMID:25583101 paracetamol affects expression ISO RGD:1558377 6480464 Acetaminophen affects the expression of RPS6KA3 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of RPS6KA3 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1354498 6480464 Acetaminophen results in decreased expression of RPS6KA3 mRNA CTD PMID:11793227 , PMID:21420995 PCB138 multiple interactions ISO RGD:1558377 6480464 [2 more ... CTD PMID:25510870 pentanal decreases expression ISO RGD:1354498 6480464 pentanal results in decreased expression of RPS6KA3 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1558377 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RPS6KA3 mRNA CTD PMID:36331819 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of RPS6KA3 mRNA CTD PMID:20345932 potassium chromate decreases expression ISO RGD:1354498 6480464 potassium chromate(VI) results in decreased expression of RPS6KA3 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1354498 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA3 mRNA CTD PMID:22079256 progesterone multiple interactions ISO RGD:1354498 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of RPS6KA3 mRNA CTD PMID:20660070 quercetin decreases expression ISO RGD:1354498 6480464 Quercetin results in decreased expression of RPS6KA3 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1354498 6480464 Lactic Acid results in decreased expression of RPS6KA3 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1354498 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of RPS6KA3 mRNA CTD PMID:23557933 sertraline decreases expression ISO RGD:1354498 6480464 Sertraline results in decreased expression of RPS6KA3 mRNA CTD PMID:24865413 silicon dioxide decreases expression ISO RGD:1354498 6480464 Silicon Dioxide analog results in decreased expression of RPS6KA3 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1558377 6480464 Silicon Dioxide results in increased expression of RPS6KA3 mRNA CTD PMID:23221170 silver atom increases expression ISO RGD:1354498 6480464 Silver results in increased expression of RPS6KA3 mRNA CTD PMID:26551752 silver(0) increases expression ISO RGD:1354498 6480464 Silver results in increased expression of RPS6KA3 mRNA CTD PMID:26551752 sirolimus affects localization ISO RGD:1558377 6480464 Sirolimus affects the localization of RPS6KA3 protein CTD PMID:19151764 sirolimus increases phosphorylation ISO RGD:1558377 6480464 Sirolimus results in increased phosphorylation of RPS6KA3 protein CTD PMID:19151764 sodium arsenite decreases expression ISO RGD:1354498 6480464 sodium arsenite results in decreased expression of RPS6KA3 mRNA CTD PMID:32844245 sulfates affects methylation ISO RGD:1354498 6480464 Sulfates affects the methylation of RPS6KA3 promoter CTD PMID:25395096 sunitinib decreases activity ISO RGD:1354498 6480464 sunitinib results in decreased activity of RPS6KA3 protein CTD PMID:21906609 tamibarotene decreases expression ISO RGD:1354498 6480464 tamibarotene results in decreased expression of RPS6KA3 mRNA CTD PMID:15498508 testosterone multiple interactions ISO RGD:1354498 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of RPS6KA3 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1354498 6480464 Testosterone results in increased expression of RPS6KA3 mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of RPS6KA3 mRNA CTD PMID:31150632 tetrahydropalmatine increases expression ISO RGD:1354498 6480464 tetrahydropalmatine results in increased expression of RPS6KA3 protein CTD PMID:20109541 thioacetamide decreases expression ISO RGD:1354498 6480464 Thioacetamide results in decreased expression of RPS6KA3 mRNA CTD PMID:11793227 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RPS6KA3 mRNA CTD PMID:23411599 , PMID:34492290 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of RPS6KA3 mRNA CTD PMID:31129395 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of RPS6KA3 mRNA CTD PMID:33387578 Triptolide increases expression ISO RGD:1558377 6480464 triptolide results in increased expression of RPS6KA3 mRNA CTD PMID:32835833 triptonide decreases expression ISO RGD:1558377 6480464 triptonide results in decreased expression of RPS6KA3 mRNA CTD PMID:33045310 urethane decreases expression ISO RGD:1354498 6480464 Urethane results in decreased expression of RPS6KA3 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1558377 6480464 Valproic Acid affects the expression of RPS6KA3 mRNA CTD PMID:17292431 valproic acid increases methylation ISO RGD:1354498 6480464 Valproic Acid results in increased methylation of RPS6KA3 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1354498 6480464 Valproic Acid results in increased expression of RPS6KA3 mRNA CTD PMID:23179753 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of RPS6KA3 mRNA CTD PMID:29427782 Y-27632 decreases activity ISO RGD:1354498 6480464 Y 27632 results in decreased activity of RPS6KA3 protein CTD PMID:10998351